[1]匡重英.肿瘤标志物CEA、CA-199联合检测在消化道肿瘤诊断中的应用价值[J].医学信息,2025,38(03):138-140,144.[doi:10.3969/j.issn.1006-1959.2025.03.027]
　KUANG Chongying.Application Value of Combined Detection of Tumor Markers CEA and CA-199 in the Diagnosis of Digestive Tract Tumors[J].Journal of Medical Information,2025,38(03):138-140,144.[doi:10.3969/j.issn.1006-1959.2025.03.027]
点击复制

肿瘤标志物CEA、CA-199联合检测在消化道肿瘤诊断中的应用价值()
分享到：

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
38卷
期数:
2025年03期
页码:
138-140,144
栏目:
论著
出版日期:
2025-02-01

文章信息/Info

Title:
Application Value of Combined Detection of Tumor Markers CEA and CA-199 in the Diagnosis of Digestive Tract Tumors
文章编号:
1006-1959（2025）03-0138-04
作者:
匡重英
泰和县人民医院检验科，江西 泰和 343700
Author(s):
KUANG Chongying
Department of Clinical Laboratory, Taihe County People′s Hospital, Taihe 343700, Jiangxi, China
关键词:
肿瘤标志物检测; 消化道肿瘤; 检测诊断
Keywords:
Detection of tumor markers;  Digestive tract tumors;  Detection and diagnosis
分类号:
R735
DOI:
10.3969/j.issn.1006-1959.2025.03.027
文献标志码:
A
摘要:
目的 探讨肿瘤标志物CEA、CA-199联合检测在消化道肿瘤诊断中的应用价值。方法 选取2020年1月-2023年12月泰和县人民医院收治的60例消化道肿瘤患者为恶性组，选择同期60例消化道良性病变患者作为良性组，健康体检者60例作为对照组。通过胃肠镜检查判断有无胃肠道肿瘤，分别检测CEA、CA-199比较各组诊断情况。结果 恶性组CEA、CA-199水平高于良性组及对照组，良性组CEA、CA-199水平高于对照组，差异有统计学意义（P＜0.05）。恶性组CEA、CA-199阳性检测率高于良性组（P＜0.05）。以手术病例活检为金标准，CEA、CA-199联合检测的诊断效能优于两项肿瘤标志物单一检测（P＜0.05）。结论 肿瘤标志物CEA、CA-199联合检测在消化道肿瘤诊断中的应用价值确切，能作为肿瘤良恶性鉴别标准，同时能够提高消化道肿瘤诊断敏感度。
Abstract:
Objective To explore the application value of combined detection of tumor markers CEA and CA-199 in the diagnosis of digestive tract tumors. Methods Sixty patients with gastrointestinal tumors admitted to Taihe County People’s Hospital from January 2020 to December 2023 were selected as the malignant group, 60 patients with benign gastrointestinal lesions were selected as the benign group, and 60 healthy subjects were selected as the control group. The presence or absence of gastrointestinal tumors was determined by gastrointestinal endoscopy. CEA and CA-199 were detected respectively, and the diagnosis of each group was compared. Results The levels of CEA and CA-199 in the malignant group were higher than those in the benign group and the control group, and the levels of CEA and CA-199 in the benign group were higher than those in the control group, the differences were statistically significant (P<0.05). The positive detection rates of CEA and CA-199 in the malignant group were higher than those in the benign group (P<0.05). With the biopsy of surgical cases as the gold standard, the diagnostic efficacy of combined detection of CEA and CA-199 was better than that of single detection of two tumor markers (P<0.05). Conclusion The combined detection of tumor markers CEA and CA-199 has definite application value in the diagnosis of digestive tract tumors, which can be used as a standard for differentiating benign and malignant tumors, and can improve the diagnostic sensitivity of digestive tract tumors.

参考文献/References:

[1]王亚磊.消化道肿瘤诊断中肿瘤标志物的检测应用与研究现状[J].检验医学与临床,2021,18(5):700-701,710.[2]郑凤帆,彭涛.上消化道黏膜下肿瘤行内镜超声微创治疗的临床观察[J].中国医药导报,2021,18(10):147-150.[3]王东琴,霍浩然,张欣,等.腹腔镜消化道肿瘤根治性术及腔内热灌注化疗联合术后生物免疫治疗对消化道肿瘤患者安全性和生活质量的影响[J].临床和实验医学杂志,2021,20(12):1283-1287.[4]刁叶秋,魏蓉,赵志娟,等.血清CEA,CA19-9联合CRP在消化道恶性肿瘤的诊断价值分析[J].现代生物医学进展,2022,22(19):3796-3800.[5]司小北,蓝宇,张硕,等.疑诊消化道恶性肿瘤患者四种常用肿瘤标志物诊断效度评价及Bayes判别式构建[J].中华肿瘤防治杂志,2020,27(18):1515-1521.[6]万健,张玉洁,王卓,等.炎症性肠病消化道肿瘤的发生风险与监测[J].中华炎性肠病杂志,2022,6(4):287-292.[7]李季,沈艳,姜研.CT仿真结肠镜联合肿瘤标志物检测在结直肠癌中的诊断价值[J].医学综述,2021,27(5):1032-1036.[8]胡先林,吴凡.血清TK1、CEA、CA19-9检测在老年胃癌诊断中的价值及其与病理特征的相关性研究[J].川北医学院学报,2021,36(8):1045-1048.[9]陆兴俊,赵太云,王胤,等.血清CA724、CA19-9水平联合内镜在胃癌诊断及预后中的价值[J].中国老年学杂志,2022,42(15):3666-3668.[10]吴娟,郑丹,阮丽蒽,等.多项肿瘤标志物联合检测在胃肠道肿瘤诊断中的价值[J].标记免疫分析与临床,2020,27(1):10-14,18.[11]李文娟,张霁雯,罗酩,等.C-13和胃蛋白酶原及肿瘤标志物联合检测在胃癌早期诊断中的作用研究[J].中国肿瘤临床与康复,2018,25(9):1069-1072.[12]刘淼,顾春瑜,王海滨.血清CRP与肿瘤标志物检测在消化道恶性肿瘤中的临床意义[J].检验医学与临床,2019,16(4):493-495,498.[13]邱黎霞,罗媛烨,葛丽卫,等.血清肿瘤标志物联合检测对胃癌诊断的价值[J].山西医药杂志,2018,47(5):584-586.[14]李东言,杜斌,郑燕君,等.结肠癌经肠镜诊断及病理结果与CEA、CA199水平的相关性分析[J].中国实验诊断学,2018,22(10):1744-1746.[15]朱媛媛,许叶涛,孙丽洲.妊娠期结肠癌伴卵巢及腹腔转移一例[J].国际妇产科学杂志,2023,50(4):437-441.[16]许婷,曲巧燕,王玥,等.上消化道早癌患者改良牵引辅助ESD治疗的微创性及远期并发症观察[J].现代消化及介入诊疗,2022,27(6):707-711.[17]罗章梅,鲍金霞.CD163在溃疡性结肠炎患者组织及血清中的表达及临床意义[J].临床消化病杂志,2023,35(5):381-385.[18]张宝月,苏云杉,杨严丽,等.十二指肠黏液囊肿1例[J].实用放射学杂志,2023,39(3):514-515.[19]郭文静,谢而付,张巧娣.不同早期消化道恶性肿瘤的血清肿瘤标志物表达差异[J].实用临床医药杂志,2021,25(5):7-9.[20]屠霖,赵恩昊.美国国立综合癌症网络食管与食管胃结合部癌临床实践指南(2022.V1-V4)更新解读[J].临床外科杂志,2023,31(1):18-20.

相似文献/References:

[1]陆昕昀,仲 骏.消化道肿瘤手术患者照顾者照护知识需求调查及影响因素分析[J].医学信息,2019,32(19):71.[doi:10.3969/j.issn.1006-1959.2019.19.021]
　LU Xin-yun,ZHONG Jun.Investigation on the Needs of Caregivers'Care Knowledge and Analysis of Influencing Factors in Patients with Digestive Tract Cancer Surgery[J].Journal of Medical Information,2019,32(03):71.[doi:10.3969/j.issn.1006-1959.2019.19.021]
[2]余海峰,赵冰清,盛冠男.胃上皮异型增生的诊断和治疗[J].医学信息,2020,33(15):50.[doi:10.3969/j.issn.1006-1959.2020.15.017]
　YU Hai-feng,ZHAO Bing-qing,SHENG Guan-nan.Diagnosis and Treatment of Gastric Epithelial Dysplasia[J].Journal of Medical Information,2020,33(03):50.[doi:10.3969/j.issn.1006-1959.2020.15.017]
[3]王政江,朱金红,王德霞,等.血清细胞质胸苷激酶对消化道肿瘤诊断价值分析[J].医学信息,2023,36(06):93.[doi:10.3969/j.issn.1006-1959.2023.06.020]
　WANG Zheng-jiang,ZHU Jin-hong,WANG De-xia,et al.Analysis of Diagnostic Value of Serum Thymidine Kinase 1 in Gastrointestinal Cancer[J].Journal of Medical Information,2023,36(03):93.[doi:10.3969/j.issn.1006-1959.2023.06.020]
[4]张亚奇,潘明胜,田彦军,等.双氢青蒿素对消化道肿瘤作用及其机制的研究进展[J].医学信息,2023,36(14):173.[doi:10.3969/j.issn.1006-1959.2023.14.038]
　ZHANG Ya-qi,PAN Ming-sheng,TIAN Yan-jun,et al.Research Progress on the Function and Mechanism of Dihydroartemisinin in Digestive Tract Tumors[J].Journal of Medical Information,2023,36(03):173.[doi:10.3969/j.issn.1006-1959.2023.14.038]

更新日期/Last Update: 1900-01-01